Elevance Health (NYSE:ELV) Upgraded at StockNews.com
Elevance Health (NYSE:ELV – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a ...
Fierce Healthcare3d
Elevance Health, Centene donated to Trump inaugural fund, key lawmakers
A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...
Elevance Health earnings boost health-insurance stocks after upbeat outlook
Elevance Health Inc.’s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered ...
Q2 EPS Estimates for Elevance Health Lowered by Analyst
Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Elevance Health in a research ...
The Washington Post16d
Elevance Health: Q4 Earnings Snapshot
INDIANAPOLIS — INDIANAPOLIS — Elevance Health Inc. (ELV) on Thursday reported fourth-quarter net income of $418 million. The Indianapolis-based company said it had net income of $1.81 per share.
Elevance Health Inc. stock underperforms Thursday when compared to competitors
Elevance Health Inc. closed 31.17% below its 52-week high of $567.26, which the company reached on September 3rd.
Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Elevance Health (ELV) and Genmab (GMAB)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurosense Therapeutics Ltd. (NRSN – Research Report), ...